Metabolic data obtained during sodium (Na) loading, restriction, and depletion with thiazide were compared in 23 patients with valvular heart disease who had cardiac indices (CI) > and < 2.5 liters/min/m2. During Na loading (80 mEq Na for 4 days, followed by 150 mEq for 4 days) patients with CI> 2.!excreted -3.4% Na load than those with the lowest normal values, whereas those with CI <2.5 excreted -20.8% (P < 0.02). All 12 patients with CI> 2.5 responded to Na loss with elevation of plasma renin activity (PRA). In contrast, of the ill patients with CI < 2.5, none of the six on the 10 mEq diet, and only two of five on thiazide, responded with an increase in PRA; the urinary aldosterone values paralleled the PRA responses. The renin-angiotensin-aldosterone system responded to changes in Na balance. The magnitude and direction of the responses were influenced by cardiohemodynamic abnormalities. Aldosterone plays an important role in the Na retention in patients with valvular heart disease by stimulating Na-K exchange in the distal tubules of the kidney.
RAUNWALD and his associates' have D devised an excellent oral sodium (Na) tolerance test that clearly demonstrates the inability of patients with congestive heart failure to excrete a Na load. Also, they found no correlation between creatinine clearance and the load of Na excreted, which confirmed earlier work2' 3 that showed that abnormalities of the glomerular filtration rate are not primarily responsible for the impaired Na excretion. Evidence is accumulating to prove that the renin-angiotensin-aldosterone system influences the level of Na excretion in patients with congestive heart failure.4-6 Brown and Spironolactone others7 have observed two distinct patterns of renin secretion in untreated patients. More commonly, plasma renin activity (PRA) was normal or low, rising with therapeutic diuresis. In other instances, renin activity was initially high and fell with treatment. We have observed these two distinct patterns with Na restriction and after administration of thiazide diuretics. We have also reported this paradoxical fall in PRA in patients with hypertensive cardiovascular disease treated with thiazide. 8 The purpose of this paper is to correlate cardiohemodynamic data with variations in PRA, urinary aldosterone excretion, and Na and K (potassium) balance during Na depletion and Na loading.
Patients and Methods
Patients with valvular heart disease were used for the study. Before they were transferred to the research ward for metabolic balance studies, the cardiovascular status was determined by methods previously described by Judson and his coworkers. 9 The Na loading studies were patterned after those used by Braunwald and his associates' for their oral Na tolerance test. After a 4-day diet of 10 mEq of Na and 90 mEq of K the patients were placed on a Na diet of 80 mEq for 4 days, followed by a Na diet of 150 mEq for the last 4 days. The basic diet was assayed for small variations in the Na and K content. Because of surgery schedules that interfered, the Na loading period had to be reduced to 6 or 7 days in a few patients. Consequently the Na intake varied from 686 to 948 mEq over the duration of the study. In order to relate the effect of changes in the reninangiotensin-aldosterone system to hemodynamic variables, advantage was taken of the data on Na excretion in normal subjects in the paper of Braunwald and associates.' By plotting their data on Na excretion by patients on Na intakes of 320 and 920 mEq, we were able to estimate the expected normal Na excretion.
In the Na depletion studies, after 3 group B, patients with CI < 2.5; group C, patients who were Na-depleted with Cl > 2.5; and group D, patients who were Na-depleted with CI <2.5. The data are presented in figure 1 .
Effect of Na Restriction and Na Depletion on PRA
The effect of Na restriction and Na depletion on the pattern of PRA is shown in figure 2 . The data on patients with Cl > 2.5 liters/min/m2 are compared with those with lower indices. All 12 patients in the groups with higher CI responded to Na loss with elevation of PRA. In contrast, none of the six patients with CI < 2.5 liters/min/m2 on the 10-mEq Na diet and only two of five patients on thiazides responded with an increase in PRA. The modifying effect of cardiohemodynamic factors on PRA as well as on aldosterone excretion will be presented later. PRA Na restriction and Na loading in two patients. On a low Na diet patient 3 ( fig. 3) , with a CI of 2.74 liters/min/m2, responded with a prompt rise in PRA that was sustained through 3 days of the 80-mEq Na period. With the increase of Na load to 150 mEq, PRA fell toward the control level. Aldosterone excretion followed the same pattern. In this patient 80% of the Na was excreted in the last 4 days, accompanying the fall in PRA. Only 20% was excreted during the first 4 days of Na loading when the PRA and aldosterone production were elevated.
In contrast, figure 4 shows that during Na restriction the PRA in patient 9 (CI = 1.96 liters/min/m2) fell from 9.5 to 3.4 ng/ml/hr. With the fall in PRA and aldosterone excretion there was only a gradual decrease in urinary Na output. With Na loading the PRA rose to the original control level and did not fall until the last 2 days of the Na tolerance test. Even though patient 3 ( fig. 3 ) had a CI of 2.74 liters/min/m2 compared to 1.96 for patient 9 ( fig. 4) , there was only a small difference in Na load excreted, expressed in percent of lowest normal Na excretion, -12.5% for patient 3 and -15.1% for patient 9.
In table 1 data are presented demonstrating changes in PRA and aldosterone excretion in the individual subjects during different stages of the Na tolerance test. The effect of acute stress on PRA and urinary Na excretion is illustrated in patients 2 and 10. Patient 2, on the first day of the 150-mEq Na diet, had a cardiogenic arterial embolus secondary to rapid atrial fibrillation. PRA rose to 13.9 ng/ml/hr. The usual reduction in urinary aldosterone with Na loading did not occur. The excretion of Na load was -70% of the lowest normal value. Patient 10 developed pneumonia with a temperature of 1020F on the second day of the 150-mEq Na loading period. PRA rose to 12.3 ng/ml/hr, and aldosterone excretion increased during the 80-mEq diet from 15 to 21 gg/ day. The Na excretion was -42.5% below normal. In both patients the insertion of prosthetic valves resulted in a marked improvement in symptoms with an increase in effort tolerance, which has been maintained for more than 2 years. Figure 5 presents the relation between cardiac indices and excretion of Na load. As a group the patients with CI > 2.5 liters/min/ m2 excreted 3.24% less Na than the lowest normal value, compared to 20.2% for the group with CI < 2.5 (P < 0.02).
Effect of Na Depletion with Thiazides on PRA and Cumulative Na and K Balance Figure 6 shows that Na depletion by means of thiazide administration caused a prompt and marked elevation of PRA in the patients with CI > 2.5 liters/min/m2 (group C). In contrast, the response was delayed until the fourth or fifth day of Na depletion in the two patients in the group with CI < 2.5 liters/ min/m2 (group D) who responded with an increase in PRA. Although there was good correlation between weight loss and cumulative Na loss (r = 0.914, P < 0.001) in patients with Na restriction or Na depletion, the relation between Na loss and PRA is more complex.
As shown in figure 6 , on the first day of Na depletion group D lost slightly less Na than Relation between cardiac indices and percent excretion of Na load. The relation of mean PRA values to cumulative Na and K balance in patients with valvular heart disease on a 10-mEq Na diet plus a thiazide diuretic. Horizontal lines mark Na depletion period. K/Na ratio varied inversely with those of the urinary Na and directly with the 24-hr urinary aldosterone excretion and PRA. The data on patient 17 demonstrate that spironolactone definitely reduced the K-Na exchange. By using the 24-hr endogenous creatinine clearance to calculate the filtered load, the profound effect of spironolactone on the Na-K exchange in the kidney could be demonstrated in the patients of groups C and D. In all nine of the patients who had received spironolactone, the K/Na ratio of percent of filtered load excreted fell from a mean value of 315 + 66 to 47 ± 4.3 (P < 0.001). The urinary Na/K ratio increased from 0.164 to 0.979 (P < 0.001). ed that in congestive heart failure there is a diminished dilator capacity of the resistance vessels which is related to an excessive Na and water content of the vasculature. The reactive hyperemic blood flow response is also diminished in hypertension in which it is established that arterial Na is elevated. The delayed or suppressed renin release by the kidney in response to thiazide in the patients in group D, where Na retention is due to heart failure, is similar to that which we recently reported'0 in patients with chronic essential hypertension with renin suppression. In both, renin suppression can be overcome. In the individual patient a critical loss of Na may be necessary before the stretch of the baroreceptors, postulated by Tobian,18' 19 can be reduced to the degree necessary for the release of renin by the juxtaglomerular cells. It is equally possible that an increased intracellular Na and decreased intracellular K concentration in the macula densa cells could inhibit the activity of the macula densa enzymes which Reeves and Sommersl5 have postulated influence renin production by the juxtaglomerular cells. With sufficient Na loss, the activity of these enzymes would be enhanced, thereby increasing renin release.
The increase in urinary aldosterone excretion without an increase in renin activity in a patient of group D, the only patient in this study with edema, may be due to a decreased rate of metabolism of aldosterone by the liver.20 ' 21 The administration of the aldosterone antagonist, spironolactone, to this patient, as well as to eight other patients, caused a marked increase in Na excretion and urinary Na/K ratio as well as in PRA. Braunwald' reported that administration of spironolactone markedly improved the response to Na load in three patients with valvular heart disease by blocking aldosterone-induced Na reabsorption. These findings are compatible with the view that increased levels of circulating aldosterone play an important role in Na and water retention, which is characteristic of heart failure.
Davis22 has concluded from his studies on congestive heart failure that "the basic mechanisms for the continued chronic retention of salt and water appear to be secondary to the prolonged alteration in renal afferent arteriolar function, release of renin, and increased aldosterone production. Sudden acute changes in glomerular filtration rate during the chronic course of heart failure contribute to alterations in Na and water excretion." Patients 2 and 10 (table 1) are examples of acute changes in Na retention with an elevation in PRA and urinary aldosterone excretion.
The data presented demonstrate the usefulness of the determinations of PRA and urinary aldosterone excretion in evaluating the mechanisms by which the kidney retains Na in patients with valvular heart disease.
